INFORMATION ABOUT OUR EXECUTIVE OFFICERS
The names, ages and positions held by the Executive Officers of the Company on August 6, 2021, are:
Name Position Age First Elected to Officer Position
David S. Taylor Chairman of the Board, President and Chief Executive Officer 63 2013
Jon R. Moeller Vice Chairman and Chief Operating Officer; Director 57 2009
Andre Schulten Chief Financial Officer 50 2021
Gary A. Coombe Chief Executive Officer – Grooming 57 2014
Mary Lynn Ferguson-McHugh Chief Executive Officer – Family Care and New Business 61 2016
Ma. Fatima D. Francisco Chief Executive Officer – Baby and Feminine Care 53 2018
Shailesh Jejurikar Chief Executive Officer – Fabric and Home Care 54 2018
R. Alexandra Keith Chief Executive Officer – Beauty 53 2017
Carolyn M. Tastad Chief Executive Officer – Health Care 60 2014
M. Tracey Grabowski Chief Human Resources Officer 53 2018
Victor Aguilar Chief Research, Development and Innovation Officer 54 2020
Deborah P. Majoras Chief Legal Officer and Secretary 57 2010 S Marc S. Pritchard Chief Brand Officer 61 2008
All the Executive Officers named above have been employed by the Company for more than the past five years. Mr. Moeller previously served as Vice Chairman, Chief Operating Officer and Chief Financial Officer (2019-2021), Vice Chairman and Chief Financial Officer (2017 – 2019) and as Chief Financial Officer (2009 – 2017). He was appointed a Director of the Company in July 2021. Mr. Schulten previously served as Senior Vice President – Baby Care, North America (2018-2021) and Senior Vice President – Finance & Accounting, Global Baby, Feminine and Family Care (2014-2018). Mr. Coombe previously served as President – Europe Selling & Market Operations (November 2014 – February 2018). Ms. Francisco previously served as President – Global Feminine Care (November 2015 – August 2018). Mr. Jejurikar previously served as President – Global Fabric Care and Brand-Building Officer Global Fabric & Home Care (November 2015 – July 2018). Ms. Keith previously served as President – Global Skin & Personal Care (November 2014 – June 2017). Ms. Tastad previously served as Group President – North America and Chief Sales Officer (June 2019 – July 2021) and Group President – North America Selling & Market Operations (January 2015 – May 2019). Ms. Grabowski previously served as Senior Vice President – Human Resources, North America Selling and Market Operations (April 2015 – July 2018). Mr. Aguilar previously served as Senior Vice President – Research & Development, Corporate Function Research & Development (January 2020 – September 2020), Senior Vice President – Research & Development, Corporate Function Research & Development and Global Fabric Care (April 2019 – January 2020), and Senior Vice President–Research & Development, Global Fabric Care; and Sector Leader, Research & Development Global Fabric and Home Care (November 2014 – April 2019).
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
10 The Procter & Gamble Company
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
ISSUER PURCHASES OF EQUITY SECURITIES
Period Total Number of
Shares Purchased Average Price Paid per
Share
Total Number of Shares Purchased as
Part of Publicly Announced Plans or
Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under Our Share
Repurchase Program
4/1/2021 – 4/30/2021 5,908,114 $135.41 5,908,114 5/1/2021 – 5/31/2021 8,038,515 136.84 8,038,515 6/1/2021 – 6/30/2021 8,184,384 134.40 8,184,384
Total 22,131,013 $135.56 22,131,013
All transactions are reported on a trade date basis and were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises.
Average price paid per share for open market transactions excludes commission.
On April 20, 2021, the Company stated that in fiscal year 2021 the Company expected to reduce outstanding shares through direct share repurchases at a value of approximately $11 billion, notwithstanding any purchases under the Company’s compensation and benefit plans. The share repurchases were authorized pursuant to a resolution issued by the Company’s Board of Directors and were financed through a combination of operating cash flows and issuance of long-term and short-term debt. The total value of the shares purchased under the share repurchase plan was $11 billion. The share repurchase plan ended on June 30, 2021.
Additional information required by this item can be found in Part III, Item 12 of this Form 10-K.